ImmunityBio (IBRX) Change in Receivables (2014 - 2026)
ImmunityBio (IBRX) reported Change in Receivables of $700000.0 for Q1 2026, down 95.23% year-over-year from $14.7 million in Q1 2025, and down 93.37% quarter-over-quarter from $10.6 million in Q4 2025.
ImmunityBio (IBRX) Change in Receivables (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 5 years of Change in Receivables data on file, last reported at $700000.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $700000.0, down 95.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.2 million (up 54.1% YoY), and the FY2025 annual result was $40.2 million, up 1603.86% from the prior year.
- Change in Receivables eased to $700000.0 in Q1 2026 per IBRX's latest filing, from $10.6 million in the prior quarter.
- Over five years, Change in Receivables peaked at $14.7 million in Q1 2025 and troughed at -$1.8 million in Q4 2024.
- A 3-year average of $5.4 million and a median of $4.1 million in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables surged 681.54% in 2025, then slumped 95.23% in 2026.
- A 3-year view of Change in Receivables shows it stood at -$1.8 million in 2024, then surged by 681.54% to $10.6 million in 2025, then slumped by 93.37% to $700000.0 in 2026.
- Business Quant data shows IBRX's Change in Receivables at $700000.0 in Q1 2026, $10.6 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 10.56 Mn |
| Dec 31, 2025 | 10.56 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Sep 30, 2015 | 25,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |